230 results · 18ms · Sources: EU EUDAMED, US FDA

Reaction Tube With Cap

Device
EU IVDD · Eu Ivd General ·Nantong EgensBiotechnology Co.,Ltd.·No longer on the market

Novel Coronavirus (2019-nCoV) Antigen Rapid Test

Basic UDI-DI
EU IVDD · Eu Ivd General ·Tianjin Bioscience Diagnostic Technology Co.,Ltd.·1 device

Reaction Tube With Cap

Basic UDI-DI
EU IVDD · Eu Ivd General ·Nantong EgensBiotechnology Co.,Ltd.·1 device

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR B AND T-CELL SUBTYPING

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

Device
EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market